Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Imfinzi plus EV wins FDA nod for cisplatin-ineligible MIBC

AstraZeneca PLC filed a Form 6-K on 16 November 2026 disclosing that the U.S. Food and Drug Administration approved Imfinzi (durvalumab) in combination with enfortumab vedotin as neoadjuvant treatment, followed by Imfinzi monotherapy as adjuvant treatment after radical cystectomy, for adult patients with muscle-invasive …

Vinay Lochav | 16 November 2026

Invivyd Posts $119.3M Nine-Month Net Loss in Q3 2026

Invivyd, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting financial results for the three and nine months ended that date.

Shwetambri Chauhan | 16 November 2026

Duke Robotics Q3 2026: Revenue $448K, Deficit Widens

Duke Robotics Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 16, 2026, disclosing revenue growth alongside a significantly expanded accumulated deficit and a substantial increase in stockholders' equity following new capital raises.

Anjali Anand | 16 November 2026

Todd Hornbeck Buys 85,912 Shares at $5.82 Average

Hornbeck Offshore Services President and CEO Todd M. Hornbeck filed a Form 4 on November 16, 2026, disclosing a open-market purchase of common stock on November 13, 2026.

Anjali Anand | 16 November 2026

Rohit Kapoor Sells 100,000 EXLS Shares at $43.24 Average

ExlService Holdings, Inc. Chairman and CEO Rohit Kapoor filed a Form 4 on November 16, 2026, disclosing a sale of 100,000 shares of common stock on November 12, 2026.

Nitish Kishor | 16 November 2026

Lexeo Therapeutics Reports Q3 2026 Results and LX2020 Data

Lexeo Therapeutics, Inc. filed a Current Report on Form 8-K on November 16, 2026, announcing financial results for the three and nine months ended September 30, 2026, along with positive interim Phase I/II clinical data for its gene therapy candidate LX2020.

Vinay Lochav | 16 November 2026

Nataly Kremer Files to Sell 4,341 Check Point Shares

Check Point Software Technologies Ltd officer Nataly Kremer filed a Form 144 notice of proposed sale of 4,341 ordinary shares, submitted on November 16, 2026.

Aditi Sarkar | 16 November 2026

What Investors Are Watching at Apple (NASDAQ:AAPL) After a Record Close Amid Chip Selloff

● Apple'sMarket Valueof about $5.18 trillion keeps it the world's most valuable company.

Nitish Kishor | 16 November 2026

Applied Materials (NASDAQ:AMAT) Slips Despite a Record Quarter as the Chip Selloff Bites

● First-quarter guidance of $11.1 billion beat expectations, but at least 10 firms cut price targets.

Nitish Kishor | 16 November 2026

Advanced Micro Devices (NASDAQ:AMD) Gives Back Its Nvidia Rally in a Sharp Slide

● Third-quarterRevenuehit a record $13.4 billion, up 45% from a year earlier.

Nitish Kishor | 16 November 2026
Support

Hi! How can we help you today?

Loading…